Have You Heard
NICE have recently updated the guidance in a number of sections of the type 2 diabetes guidelines (NG28). New information on sodium–glucose cotransporter 2 (SGLT-2) inhibitors has been added to the section on initial drug treatment when metformin is contraindicated or not tolerated.
A new survey from the Atrial Fibrillation society shows a high level of demand for self-monitoring in people being treated with warfarin. In the survey, 79% of respondents said that they would prefer to self-monitor over clinic visits. New self- monitoring products are being launched.